Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017)

Insight Molecular Diagnostics' (IMDX) quarterly Change in Acquisitions & Divestments came in at $432000.0 in Q2 2017, down 13.94% quarter-over-quarter from $502000.0 in Q1 2017.

Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017) Analysis & Trends

Insight Molecular Diagnostics has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting $432000.0 for Q2 2017.

  • Change in Acquisitions & Divestments for Q2 2017 came in at $432000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $934000.0 (changed N/A YoY), and the FY2023 annual result was $367000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at $432000.0 for Q2 2017 at Insight Molecular Diagnostics, down from $502000.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $771000.0 in Q4 2015 to a low of $432000.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Insight Molecular Diagnostics 4.34 Mn -24.59 Mn 15,000.00

Historic Data

Download Data
DateValue
Jun 30, 2017 432,000.00
Jun 30, 2017 432,000.00
Mar 31, 2017 502,000.00
Mar 31, 2017 502,000.00
Dec 31, 2015 771,000.00
Dec 31, 2015 771,000.00